MIM 2017 “Microbes, Immunity and Metabolism international conference”
Think tank: Metabolism
We are pleased to announce the next Microbes, Immunity and Metabolism international conference www.metamim-2017.org , to be held in Paris at the Institut Pasteur on November 15th-17th, 2017. Recent studies highlight the extensive metabolic […]
Therapeutic potential of mycolactone surrogates
Inflammation adversely affects the health of millions of people worldwide and there is an unmet medical need for better anti-inflammatory drugs. Our group evaluates the therapeutic interest of mycolactone, a polyketide-derived macrolide produced by […]
Mycolactone of M. ulcerans and immunodulation
Mycolactone is a diffusible macrolide produced by Mycobacterium ulcerans, the causative agent of a chronic skin disease called Buruli ulcer. Defective cellular immune responses, at the local and systemic levels, are hallmarks of Buruli […]
Biomarkers of Buruli ulcer disease
Buruli ulcer is the third most common mycobacterial disease after Tuberculosis and Leprosy. It is a chronic, necrotizing disease of the skin and soft tissues that is reported in over thirty tropical and subtropical […]
Mycobacterial phenolic glycolipids and innate host defenses
Across different species of mycobacteria, phenolic glycolipids (PGL) share a common lipid core and phenol ring that are embedded in the cell envelope, and differ in the saccharidic portion that is exposed on the […]
Mycolactone of M. ulcerans and the actin cytoskeleton
A distinctive feature of the human pathogen Mycobacterium ulcerans is the production of mycolactone. This original polyketide-derived macrolide is essential for bacterial virulence and sufficient to induce ulcerative lesions in the skin that are […]
2017Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export, Proc. Natl. Acad. Sci. U.S.A. 2017 Jul;.
2017Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells, EMBO J. 2017 May;.
2017Pathogenic and immunosuppressive properties of mycobacterial phenolic glycolipids, Biochimie 2017 Mar;.
2016Mycolactone subverts immunity by selectively blocking the Sec61 translocon, J. Exp. Med. 2016 Dec;213(13):2885-2896.
2016Standardized Whole-Blood Transcriptional Profiling Enables the Deconvolution of Complex Induced Immune Responses, Cell Rep 2016 Sep;16(10):2777-91.
2015Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease, Sci Rep 2015;5:17693.
2015Shaping mycolactone for therapeutic use against inflammatory disorders, Sci Transl Med 2015 May;7(289):289ra85.
2014Synthetic variants of mycolactone bind and activate Wiskott-Aldrich syndrome proteins, J. Med. Chem. 2014 Sep;57(17):7382-95.
2014Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings, J Wound Care 2014 Aug;23(8):417-8, 422-4.
2014Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease, PLoS Negl Trop Dis 2014 Apr;8(4):e2786.
+Voir la liste complète de publications